FDA Accepts Filing of BETACONNECT™* for Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON® (interferon beta-1b)
PR Newswire, 22 Apr 2015
Accessed on 28 Apr 2015 from http://www.prnewswire.com/news-releases/fda-accepts-filing-of-betaconnect-for-relapsing-remitting-multiple-sclerosis-patients-taking-betaseron-interferon-beta-1b-300070199.html.